JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Six weeks to 45 years: a longitudinal study of a population with Down syndrome.

BACKGROUND: A population sample of people with Down Syndrome, repeatedly studied since infancy, has now been followed up at the age of 45 years. The paper is intended to give an overview of their abilities, as represented by the results of psychological tests, over their life span to date.

METHODS: As at all previous occasions from age 30 onwards, intelligence, language, academic abilities and memory were tested, and self-help skills assessed.

RESULTS: Mean IQs, both non-verbal and verbal, changed little from age 21 to 45. Disregarding the scores of two women severely affected by dementia, the remainder of the cohort lost over the whole period an average of less than one point in non-verbal IQ and gained over five months in verbal age. Scores on memory tests by some of those not yet diagnosed with AD declined, in some cases significantly, suggesting that other members of the cohort too may be showing the early signs of the disease.

CONCLUSIONS: While most of the cohort show few indications of decline in ability, a number now are or may be affected by AD, and this may require closer monitoring in the future.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app